Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal A T Baltzer

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
European Radiology|June 7, 2020
The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening examsRuxandra Iulia Milos, Francesca Pipan, Anastasia Kalovidouri, et al.
European Radiology|July 4, 2021
Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imagingKathrin Barbara Krug, Christina Jane Burke, Kilian Weiss, et al.
European Journal of Radiology|April 5, 2011
Artificial Neural Networks for differential diagnosis of breast lesions in MR-Mammography: a systematic approach addressing the influence of network architecture on diagnostic performance using a large clinical databaseMatthias Dietzel, Pascal A T Baltzer, Andreas Dietzel, et al.
Clinical Imaging|November 14, 2008
Diagnosis of ductal carcinoma in situ using contrast-enhanced magnetic resonance mammography compared with conventional mammographyTibor Vag, Pascal A T Baltzer, Diane M Renz, et al.
Insights Into Imaging|June 12, 2025
Cost-effectiveness of contrast-enhanced breast MRI in suspicious mammographic microcalcificationsBarbara J Fueger, Fabian Tollens, Clemens G N Kaiser, et al.
European Journal of Radiology|September 20, 2024
Evaluation of apparent diffusion coefficient (ADC) with regards to reproducibility and diagnostic accuracy as well as possible significance of pre - and post - contrast acquisition and employment of different b valuesRaoul Varga, Barbara J Fueger, Francesca Ferrara, et al.
European Journal of Radiology|June 3, 2019
Intra- and inter-observer variability in dependence of T1-time correction for common dynamic contrast enhanced MRI parameters in prostate cancer patientsMichaela Daniel, Stephan H Polanec, Georg Wengert, et al.
European Journal of Radiology|April 20, 2023
Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRIMartin Daniaux, Leonhard Gruber, Tobias De Zordo, et al.
European Journal of Radiology|November 16, 2016
Diagnostic performance of digital breast tomosynthesis with a wide scan angle compared to full-field digital mammography for the detection and characterization of microcalcificationsPaola Clauser, Georg Nagl, Thomas H Helbich, et al.
NMR in Biomedicine|May 11, 2011
Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?Pascal A T Baltzer, Alexander Gussew, Matthias Dietzel, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
European Radiology|June 7, 2020
The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening examsRuxandra Iulia Milos, Francesca Pipan, Anastasia Kalovidouri, et al.
European Radiology|July 4, 2021
Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imagingKathrin Barbara Krug, Christina Jane Burke, Kilian Weiss, et al.
European Journal of Radiology|April 5, 2011
Artificial Neural Networks for differential diagnosis of breast lesions in MR-Mammography: a systematic approach addressing the influence of network architecture on diagnostic performance using a large clinical databaseMatthias Dietzel, Pascal A T Baltzer, Andreas Dietzel, et al.
Clinical Imaging|November 14, 2008
Diagnosis of ductal carcinoma in situ using contrast-enhanced magnetic resonance mammography compared with conventional mammographyTibor Vag, Pascal A T Baltzer, Diane M Renz, et al.
Insights Into Imaging|June 12, 2025
Cost-effectiveness of contrast-enhanced breast MRI in suspicious mammographic microcalcificationsBarbara J Fueger, Fabian Tollens, Clemens G N Kaiser, et al.
European Journal of Radiology|September 20, 2024
Evaluation of apparent diffusion coefficient (ADC) with regards to reproducibility and diagnostic accuracy as well as possible significance of pre - and post - contrast acquisition and employment of different b valuesRaoul Varga, Barbara J Fueger, Francesca Ferrara, et al.
European Journal of Radiology|June 3, 2019
Intra- and inter-observer variability in dependence of T1-time correction for common dynamic contrast enhanced MRI parameters in prostate cancer patientsMichaela Daniel, Stephan H Polanec, Georg Wengert, et al.
European Journal of Radiology|April 20, 2023
Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRIMartin Daniaux, Leonhard Gruber, Tobias De Zordo, et al.
European Journal of Radiology|November 16, 2016
Diagnostic performance of digital breast tomosynthesis with a wide scan angle compared to full-field digital mammography for the detection and characterization of microcalcificationsPaola Clauser, Georg Nagl, Thomas H Helbich, et al.
NMR in Biomedicine|May 11, 2011
Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?Pascal A T Baltzer, Alexander Gussew, Matthias Dietzel, et al.
Pageof 17